Key statistics
On Friday, Hims & Hers Health Inc (HIMS:NYQ) closed at 25.33, -16.79% below its 52-week high of 30.44, set on Nov 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 23.72 |
---|---|
High | 25.37 |
Low | 23.03 |
Bid | -- |
Offer | -- |
Previous close | 24.15 |
Average volume | 27.76m |
---|---|
Shares outstanding | 218.48m |
Free float | 184.41m |
P/E (TTM) | 58.55 |
Market cap | 5.53bn USD |
EPS (TTM) | 0.4326 USD |
Data delayed at least 15 minutes, as of Nov 22 2024 21:10 GMT.
More ▼
- Hims & Hers Expands Nutrition Support to Fuel Customers’ Weight Loss Journeys
- Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions
- Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue
- Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
- How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
- Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers
- Hims & Hers to Announce Third Quarter 2024 Financial Results on November 4, 2024
- Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
More ▼